Replies to post #162585 on Biotech Values

[biomaven0]

The Chugai drug starts with a strike against it I think because there are a couple of mutations it very likely can't handle.

'113 in theory should be able to handle the known mutations (except perhaps I1171N, which none of the disclosed drugs can handle well), although some have raised doubts about G1202R.

Peter